Table 1. CD38 expression in basal... | American Society of Hematology

Table 1.

CD38 expression in basal conditions and on IL-2 treatment in the B-CLL sample analyzed

			Basal CD38			CD38/IL-2
Patient no.	Age, y	Sex	%	MFI	%	MFI
1	65	M	71	13	ND	ND
2	63	F	8	6	ND	ND
3	52	F	89	51	98	155
4	55	M	55	24	93	123
5	68	M	58	36	70	254
6	63	M	4	12	33	48
7	69	M	1	13	ND	ND
8	76	M	62	36	88	260
9	66	F	7	16	77	209
10	49	M	14	14	6	7
11	74	M	76	35	94	73
12	64	M	82	40	98	128
13	81	F	1	12	13	60
14	74	F	70	33	88	261
15	54	F	34	10	59	27
16	61	M	2	4	8	11
17	67	M	12	11	18	18
18	54	M	7	8	98	96
19	61	M	61	13	94	98
20	65	F	53	15	75	59
21	77	M	40	14	86	196
22	78	F	1	4	8	10
23	77	F	39	41	41	92
24	67	F	6	7	73	41
25	73	M	7	7	16	16
26	65	F	1	10	6	10
27	62	M	37	17	76	75
28	62	F	1	7	8	10
29	63	M	75	28	76	45
30	61	M	18	21	32	29
31	72	F	75	35	88	67
32	67	F	76	15	77	88
33	58	M	66	26	93	80

			Basal CD38			CD38/IL-2
Patient no.	Age, y	Sex	%	MFI	%	MFI
1	65	M	71	13	ND	ND
2	63	F	8	6	ND	ND
3	52	F	89	51	98	155
4	55	M	55	24	93	123
5	68	M	58	36	70	254
6	63	M	4	12	33	48
7	69	M	1	13	ND	ND
8	76	M	62	36	88	260
9	66	F	7	16	77	209
10	49	M	14	14	6	7
11	74	M	76	35	94	73
12	64	M	82	40	98	128
13	81	F	1	12	13	60
14	74	F	70	33	88	261
15	54	F	34	10	59	27
16	61	M	2	4	8	11
17	67	M	12	11	18	18
18	54	M	7	8	98	96
19	61	M	61	13	94	98
20	65	F	53	15	75	59
21	77	M	40	14	86	196
22	78	F	1	4	8	10
23	77	F	39	41	41	92
24	67	F	6	7	73	41
25	73	M	7	7	16	16
26	65	F	1	10	6	10
27	62	M	37	17	76	75
28	62	F	1	7	8	10
29	63	M	75	28	76	45
30	61	M	18	21	32	29
31	72	F	75	35	88	67
32	67	F	76	15	77	88
33	58	M	66	26	93	80

ND indicates not determined.